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Effect of divalent cation ionophore (A 23187) on renal
handling of phosphorus
MORDECAL M. POPOVTZER, RAYMOND S. FLIs, SUSHIL K. MEHANDRU and MURRAY BLUM
Department of Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania
Effect of divalent cation ionophore (A 23187) on renal handling of
phosphorus. To evaluate the effect of an increase in intracellular
calcium on renal handling of phosphorus, calcium ionophore,
which facilitates passive entry of calcium into cytosol, was given
i.v. to four groups of rats: group I, animals with intact parathyroid
glands; group 2, parathyroidectomized (PTX) rats; group 3, PTX
animals receiving iv. parathyroid hormone (PTH); and group 4,
PTX animals pretreated with i.v. ionophore, then given i.v. PTH.
During the administration of ionophore in group 1, serum calcium
(S) decreased from 8.7 0.2 (mean SaM) to 7.5 + 0.2 mg/lOO
ml (P < 0.001), fractional excretion of phosphorus (C9/C1) de-
creased from 0.110 0.020 to 0.0 19 0.006 (P < 0.001), and
urinary cyclic 3', 5'-adenosine monophosphate (UCAMP) decreased
from 131 + 23 to 46 16 pmoles/min (P < 0.0125). In group 2,
during the administration of ionophore, Sc decreased from 6.5
0.2 to 5.7 0.2 mg/lOO ml (P < 0.001), but neither Ce/C,,, nor
UCAMP were altered. In group 2, during the administration of
ionophore, C/C1 decreased from 0.43 + 0.05 to 0.19 0.04 (P <
0.005), UCAMP decreased from 254 20 to 159 11 (P<0.001). In
group 4, during combined iv. administration of ionophore and
PTH, C/C1 was reduced from 0.19 0.009 to 0.044 0.0l2(P <
0.005), and serum calcium was reduced from 6.5 0.3 to 5.1 0.3
mg/l00 ml (P < 0.01). These findings indicate that i.v. ionophore
suppresses urinary excretion of phosphorus, only in the presence of
either endogenous or exogenous PTH. The associated decrease in
UCAMP suggests that this effect could be mediated through inhibi-
tion of PTH-dependent formation of cAMP, possibly resulting
from the ionophore-induced increase in intracellular calcium in
renal tubular cells.
Effet d'un ionophore des cations divalents (A 23187) sur le corn-
portement renal vis a vis du phosphate. Afin d'évaluer l'effet de
I'augmentation du calcium intracellulaire sur le comportement
renal vis a vis du phosphore, on a donné a quatre groupes de rats
un ionophore de calcium qui facilite l'entrée passive de ce cation
dans Ic cytosol. Le groupe I est compose d'animaux dont les
parathyroldes sont intactes, le groupe 2 d'animaux parathy-
roldectomisCs (PTX), Ic groupe 3 d'animaux PTX recevant de
l'hormone parathyroTdienne (PTH) par voie intra-veineuse et Ic
groupe 4 d'animaux pré-traités par l'ionophore qui recoivent de Ia
PTH. Au cours de l'administration de l'ionophore au groupe I, Ic
calcium séreique (Sca) diminue de 8,7 + 0,2 (iii + SEM) 7,5 0,2
mg/100 ml (P < 0,001), l'excrétion fractionnelle du phosphore
(C/C1,,) diminue de 0,110 0,020 a 0,019 0,006 (P <0,001)et
I'AMP cyclique urinaire (UCAMP) diminue de 131 + 23 a 46 16
pmoles/min (P < 0,0125). Dans Ic groupe 2, au cours de
l'administration de l'ionophore, S, diminue de 6,5 0,2 a 5,7
0,2 mg/100 ml (P < 0,001), mais ni C/C1,, ni UCAMP ne sont
modifies. Dans Ic groupe 3, au cours de I'administration de
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l'ionophore, Cp/C1 diminuede254 + 20a 159 II (P <0,001).
Dans Ic groupe 4, au cours de l'administration combinCe
d'ionophore et de PTH, C,./C1,, diminue de 0,19 0,009 a 0,004
0,012 (P < 0,005) et S, de 6,5 0,3 a 5,1 0,3 mg/l00 ml (P <
0,01). Ces constatations indiquent que l'ionophore ne diminue
l'excrétion urinaire de phosphate qu'en presence de PTH endogCne
ou exogéne. La baisse associée de UCAMP suggère que cet effet peut
avoir pour médiateur l'inhibition de Ia formation d'AMP cyclique
dépendante de Ia PTH, consequence de l'augmentation du calcium
intracellulaire dans les cellules tubulaires rénales, induite par
I'ionophore.
Hypercalcemia enhances tubular reabsorption of
phosphorus by inhibiting endogenous secretion of
parathyroid hormone [1,2], whereas restoration of
serum calcium to normal in hypoparathyroidism
causes phosphaturia by an unknown mechanism [3].
In addition, it has been proposed that hypercalcemia
may act directly on the kidney to reduce urinary
excretion of phosphorus, through several different
mechanisms [2—9]. First, hypercalcemia may increase
phosphate reabsorption by stimulating a parathyroid
hormone-independent transport system in the kidney
[5,6]. Second, hypercalcemia may suppress the
phosphaturic effect of parathyroid hormone by inhib-
iting the hormone-induced activation of renal adeny-
late cyclase [7]. In a recent study, we were unable to
demonstrate suppression of the phosphaturic action
of parathyroid hormone by acute hypercalcemia in
parathyroidectomized rats, even though i.v. calcium
blunted the phosphaturic response to volume expan-
sion [10]. These observations did not exclude the pos-
sibility that an increase in the intracellular calcium,
as opposed to an increase in extracellular calcium,
may interfere with the phosphaturic response to para-
thyroid hormone. The present study was designed to
explore the latter possibility. To produce an increase
in intracellular calcium, we employed a divalent
cation ionophore which facilitates a passive entry of
calcium into the cytoplasm and thus may suppress
the activity of adenylate cyclase [11—14]. The iono-
phore does not disrupt the functional integrity of the
cell membrane and does not interfere directly with
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the energy metabolism [13]. The results of the present
study support the role of intracellular calcium in
altering the renal response to parathyroid hormone.
Methods
White, female Sprague-Dawley rats (weighing 250
to 350 g) fed pellet chow diet (livestock and Poultry
Feeds, Ralston Purina Co., St. Louis, MO) with tap
water ad lib were studied.
Clearance studies. The clearance studies were per-
formed in all animals at the same part of the day,
between 8:00 A.M. and 4:00 P.M. After induction of
anesthesia with an i.m. injection of sodium pentobar-
bital (40 mg/g of body wt), the animals were placed
on heated operating boards and tracheostomy tubes
were inserted. Rectal temperature was monitored by
means of a thermistor and telethermometer (Yellow
Springs Instrument Co., Yellow Springs, OH). The
femoral artery and vein were exposed through in-
guinal incisions and PE-20 tubings (Clay Adams, Di-
vision of Becton, Dickinson, and Co., Parsippany,
NJ) were inserted into each vessel. The arterial line
was used for monitoring mean arterial blood pres-
sure with a strain gauge (model 23AA, Statham In-
struments, Inc., Oxnard, CA) and for the collection
of blood samples. The venous line was extended to a
syringe mounted on a variable speed continuous-in-
fusion pump (Harvard Apparatus Co., Inc., Millis,
MA). The urinary bladder was exposed and a funnel-
shaped end of a PE-240 tubing was introduced
through an incision at the fundus for urine collec-
tions. The incision was closed tightly with a purse
string suture which excluded a major portion of the
vesical lumen and thus eliminated most of the dead
space. The technique of measuring inulin clearances
(C1) in rats and the analytical procedures used in our
laboratory have been previously described in detail
[15]. The sustaining infusion of inulin was given in
5% dextrose in water at the rate of 1.5 ml/l00 g/hr.
All plasma and urine specimens were analyzed for
inulin [16] and phosphorus, and at least two plasma
specimens obtained at the beginning and the end of
each experiment were analyzed for calcium. Inor-
ganic phosphorus was measured utilizing the meth-
odology developed by the American Monitor Co.
(American Monitor Patent No. 3-547-586), which is
an automated modification of the method originally
described by Fiske and Subbarow [17]. Calcium was
determined with an atomic absorption spectro-
photometer (model 290, Perkin-Elmer Corp., Nor-
walk, CT). The fractional phosphorus clearance was
determined by factoring the clearance of phosphorus
(Cr) by the clearance of inulin (C1). Urinary cyclic
3',S'-adenosine monophosphate (cAMP) was deter-
mined in duplicates by the protein binding assay de-
scribed by Gilman [18]. Calcium specific ionophore
A 23187 (Eli Lilly and Company, Indianapolis, IN)
was initially dissolved in a small amount of dimethyl
sulfoxide (DMSO); 5 mg of ionophore in 0.25 ml of
DMSO was used as the stock solution. For each
individual experiment, the necessary amount of iono-
phore was obtained from the stock solution and dis-
solved in plasma separated from blood of rats similar
to the experimental animals. In control groups,
DMSO in equal volume but without ionophore was
added to the plasma. In all experiments, the iono-
phore was given i.v. at the rate of 0.20 mg/kg of body
wt/hr in the volume of 1 ml of plasma per hr. In
preliminary testing, this dose was found to be well
tolerated by most of the animals that were studied.
Administration of higher doses of ionophore pro-
duced frequently a fall in blood pressure with a de-
crease in glomerular filtration. Animals that exhib-
ited a decrease in blood pressure or glomerular
filtration rate in response to a smaller dose of iono-
phore and their controls were excluded from the
study.
Experimental groups: Group 1. In ten rats with
intact parathyroid glands, after three control collec-
tions (each urine collection, 30 mm), i.v. ionophore
was given for four consecutive collections. Ten rats
treated in a similar fashion but not receiving iono-
phore served as control.
Group 2. Parathyroidectomy (PTX) was performed
two days before the clearance studies. In 12 PTX rats,
following three control collections, ionophore was
given i.v. for four consecutive periods. Twelve PTX
rats treated in a similar fashion but not receiving the
ionophore served as control.
Group 3. In eight PTX rats, after two control col-
lections, parathyroid extract (PTE) (Eli Lilly and
Co., Indianapolis, IN) was started i.v. at the rate of 1
U/lOO g/hr. PIE was dissolved in 5% dextrose in
water and given at the rate of 1 ml/min. After two
clearance periods with PTE, i.v. ionophore was
added and given with PTE for another four con-
secutive collections. Eight PTX rats treated in a sim-
ilar fashion but not receiving the ionophore served as
control.
Group 4. In four PTX rats after two control collec-
tions, i.v. ionophore was begun. After two clearance
periods with ionophore, i.v. PTE was begun at the
rate of 1 U/lOO g/hr and was given with ionophore
for another two colelction periods. Four additional
PTX rats treated in a similar fashion but not receiv-
ing ionophore served as control.
In all experiments, the results were analyzed by
comparing the experimental with the corresponding
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Fig. 1. The effect of calcium ionophore on average serum calcium
concentrations in intact rats before (B) and during (E) the adminis-
tration of the ionophore in the experimental animals and administra-
(ion of the vehicle in the control rats. P refers to the difference
between baseline and the experimental periods.
control groups, using the Student's t test. All results
are presented in terms of mean SEM.
Results
Figure 1 depicts the effect of the ionophore on
serum calcium concentrations in rats with intact para-
thyroid glands (group 1). Serum calcium decreased
from a baseline of 8.7 + 0.2 to an average of 7.5 0.2
mg/100 ml (P < 0.001) during the administration of
the ionophore. In the control animals, there was no
change in serum calcium, and the corresponding con-
centrations were 8.7 0.2 and 8.5 0.2 mg/l00 ml
(P = NS). The average glomerular filtration rates for
group 1 before and during the infusion of the iono-
phore are listed in Table 1. During all collection
periods, there was no significant difference between
the experimental and control animals. Likewise, there
was no significant difference in serum phosphorus
concentrations between the experimental and control
animals.
Figure 2 depicts the alterations in fractional excre-
tion of phosphorus to inulin (C/C1) in group 1.
During the baseline collections (0 to 90 mm), there
was no difference between the experimental and con-
trol animals. During the administration of the iono-
phore to the experimental animals (90 to 210 mm),
C/C1 in the control animals increased to 0.110
0.020. In the experimental animals, C/C1 decreased
to 0.019 0.006 during the administration of the
ionophore, resulting in a highly significant discrep-
ancy between the control and experimental animals.
Figure 3 shows the alterations in urinary excretion of
cAMP following the administration of the iono-
phore. The data represent average values obtained by
measuring cAMP in aliquots of pooled urine collec-
tions, both for the baseline (0 to 90 mm) and the
experimental periods (90 to 210 mm). There was no
difference in urinary excretion of cAMP between the
control (119 26 pmoles/min) and the experimental
animals (158 20) during the baseline collections.
During the administration of the ionophore, urinary
cAMP in the experimental animals decreased to 46
16 pmoles/min and remained unchanged in the con-
trol animals, 131 23 pmoles/min, resulting in a
highly significant discrepancy between the control
and the experimental animals. There was no signifi-
cant difference between the groups in urinary excre-
tion of calcium throughout all collection periods.
Figure 4 illustrates the effect of the ionophore on
serum calcium concentrations in chronically PTX
rats (group 2). In the experimental animals, serum
calcium decreased from a baseline concentration of
6.5 0.2, to 5.7 0.2 mg/l00 ml (P<0.001),
whereas in the control animals the corresponding
calcium concentrations were 6.5 0.3 and 6.6
mg/100 ml (P=NS). Table 1 presents the glomerular
filtration rates before and during the administration
of the ionophore in group 2. During all collection
periods, there was no difference between the control
and experimental animals. Likewise, there was no
differepce in serum phosphorus concentrations and
Table 1. Inulin clearances during all collection periods in all groups of animals
Oto3O
mm.
30 to 60
mm.
60 to 90
mm.
9Oto 120
mm.
120 to 150
mm.
150 to 180
mm.
180 to 210
mi
210 to 240
mm.
Group I
.
Exp. (N = 10) 3.1 0.4 3.8 0.4 3.4 0.6 3.1 0.5 3.0 0.4 2.8 0.4 3.2 0.4 —
Control (N = 10) 3.6 0.4 3.5 + 0.3 2.7 + 0.3 3.9 0.2 3.6 0.2 2.6 + 0.5 3.3 + 0.3 —
Group 2
Exp.(N = 12) 3.0 + 0.3 3.3 0.3 3.4 + 0.3 3.5 + 0.3 3.4 + 0.2 3.2 + 0.3 3.2 0.4 —
Control (N = 12) 3.2 + 0.3 3.3 + 0.3 3.4 0.2 3.5 + 0.2 3.7 0.2 3.6 0.2 3.6 0.2 —.
Group 3
Exp.(N = 7) 3.9 0.3 3.6 + 0.3 3.0 0.3 4.0 0.4 3.1 0.3 3.1 0.4 3.2 0.3 3.4 0.3
Control (N = 7) 3.6 + 0.3 4.2 + 0.6 3.9 + 0.6 3.9 + 0.3 3.8 + 0.2 3.7 + 0.3 4.0 + 0.4 3.2 + 0,2
Exp. denotes experimental group. N = number of animals used. All values are + SEM.
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Fig. 4. The effect of calcium ionophore on average serum calcium
concentrations in parathyroidectomized rats. before (B) and during
(E) the infusion of lonophore in the experimental animals and the
infusion of the vehicle in the control rats. P refers to the difference
between the baseline and experimental periods.
0.04, whereas in the control animals that received
parathyroid hormone, only C/C1 continued to in-
crease, reaching a peak value of 0.43 0.05. This
resulted in a highly significant difference between the
control and experimental animals. These changes
were not associated with significant alterations in
serum phosphorus or glomerular filtration rates
(Table 1). Figure 7 illustrates the variations in
urinary excretion of cAMP in group 3. During the
baseline collections (0 to 60 mm), there was no differ-
ence between the experimental, 34 18 pmoles/min,
and the control animals, 55 20 pmoles/min (P =
NS). During the administration of parathyroid hor-
mone (60 to 120 mm), urinary cAMP increased
equally in the control, 281 43 pmoles/min, and the
experimental animals, 289 23 pmoles/min. During
the administration of the ionophore, however,
urinary cAMP decreased to 159 11 pmoles/min in
the experimental animals and remained unchanged in
the control animals, 254 20 pmoles/min, resulting
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Fig. 2. The effect of calcium ionophore on renal handling of phos-
phorus in intact rats. P refers to the difference between the control
and the experimental rats.
urinary excretion of calcium and cAMP. Figure 5
shows the variations in C/C1 in group 2. There was
no difference between the experimental and control
animals before (0 to 90 mm) and during the adminis-
tration of the ionophore (90 to 210 mm).
Figure 6 depicts the alterations in C/C1 in group
3. During the baseline collections (0 to 60 mm) and
during the administration of parathyroid hormone
(60 to 120 mm), there was no significant difference
between the control and experimental animals. Dur-
ing the combined administration of parathyroid hor-
mone and ionophore (120 to 240 mm), C/C1 in the
experimental animals diminished to a nadir of 0.19
0 Control
200 - • lOflOPh0
100 -
0 Control
0.05 - • lonophore
Co
C,
o CO
CCCoo 0.03
P NS
0.02
30.90
<0.0125
0.01
Time, rn/n
Fig. 3. The effect of calcium ionophore on urinary excretion of
cAMP. The symbols represent excretion rates derived from
pooled urine collections. P refers to the difference between the
experimental and control animals.
90-120 30 60 90 120 150 180 210
I I C C I I
Time. mm
Fig. 5. The effect of calcium ionophore on renal handling of phos-
phorus in parathyroidectomized rats. There was no significant dif-
ference between the control and the experimental animals during
all collection periods.
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in a significant discrepancy in urinary excretion of
cAMP between these two subgroups. There were no
significant differences in serum concentrations or
urinary excretion rates of calcium. The average serum
calcium concentration decreased from a baseline of
7.1 0.3 to an experimental level of 6.5 mg/100
ml; this fall, however, was not significant.
Table 2 shows the changes in serum concentrations
of calcium and phosphorus, inulin clearances, and
fractional excretion of phosphorus in group 4. In the
experimental animals, serum calcium concentration
(Sça), during the combined infusion of ionophore and
PTH (Sea, 5.1 0.3), was lower than that in the
0 PTH
300 • PTH + lonophore
Table 2. Average serum concentrations of calcium (S) and phosphorus (Sp), inulin clearances (C1) and fractional excretion of phosphorus
(C/C1) in four experimental parathyroidectomized (PTX) rats during two baseline periods (0 to 60 mm), two ionophore periods (60 to
120 mm) and two ionophore + parathyroid hormone (PTH) periods (120 to 180 mm) compared with corresponding values in four control
PTX rats not receiving ionophore.
Baseline lonophore lonophore + PTH
C1,, Cp Sc,, Sp Ci,, Cp Sca S C1,, Cp S< Sp
mi/mm T mg/lOU ml mi/mm mg/lOOm! mi/mm ' mg/IOU ml
Experimental rats
1 2.50 0,050 7.0 6.5 2.10 0.055 6.2 7.0 1.60 0.012 5.! 6.4
2 2.45 0.015 7.1 4.5 2.32 0.015 6.9 4.4 2.70 0.045 6.0 5.1
3 3.40 0.045 6.9 7.1 3.65 0.035 6 ) 6.5 2.22 0.075 5.0 5.4
4 3.60 0.012 5.9 7.8 3.60 0.056 5.9 6.4 3.82 0.045 4.5 7.0
Mean 2.99 0.030 6.7 6.5 2.92 0.040 6.2 6.1 2.58 0.044 5.1 6.0
SEM 0.29 0.009 0.3 0.7 0.41 0.009 0.2 0.6 0.47 0.012 0.3 0.4
Control rats
1 3.85 0.023 7.1 6.4 3.95 0.019 6.9 6.5 3.95 0.136 6.9 5.4
2 3.98 0.002 5.9 6.0 3.33 0.002 5.6 5.4 3.18 0.106 5.7 5.1
3 2.50 0.065 6.5 7.5 2.51 0.056 6.6 7.1 2.15 0.101 6.6 7.2
4 1.81 0.048 7.4 5.4 1.75 0.042 7.0 5.5 1.65 0.095 7.0 5.9
Mean 3.03 0.034 6.7 6.3 2.88 0.030 6.5 6.1 2.73 0.109 6.5 5.9
SEM 0.52 0.013 0.3 0.4 0.48 0.011 0.3 0.4 0.52 0.009 0.3 0.5
p NS NS NS NS NS NS NS NS NS <0.005 <0.01 NS
Relates to the dilTerence between the experimental and control animals.
0 PTH
0.50 - PTH + lonophore
0.40 -
0.30 -
0.20 -
0.10 -
a,
'aC
a, C
0.
Fig. 6. The effect of calcium ionophore on renal handling of phos-
phorus in parathyroidectornized rats receiving iv. parathyroid hor-
mone. P refers to the difference between the control and experimen-
tal animals.
P NS NS,ó2'1 NS
200
100 -
NS <0.05<0.05< 0.005
30 60 90 120 150 180 210 240
Time, rn/n
P NS
lonophore
PTH
NS <0.001
30-60 60-120
Time, rn/n
120.240
Fig. 7. The effect of calcium ionophore on urinary excretion of
cAMP in parathyroidectomized rats receiving iv. parathyroid hor-
mone (PTH). The symbols represent excretion rates derived from
pooled urine collections. P refers to the difference between the
control and the experimental animals.
control animals (6.5 0.3, P<0.O1) and also lower
than that recorded in the same animals during the
baseline clearances (6.7 + 0.3 mg/100 ml, P<0.0l).
During PTH infusion, the C/C10 in the control ani-
mals (0.109 0.009) was lower than the C./C1,. in
the experimental animals (0.044 0.012, P<0.005)
that were receiving a combination of ionophore and
PTH.
Discussion
The present study has demonstrated that calcium
ionophore reduces urinary excretion of phosphorus
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in rats. Since no consistent changes in the filtered
load were noted, if may be concluded that the iono-
phore produced a net increase in tubular reabsorp-
tion of phosphorus. The associated decrease in serum
calcium concentration, in absence of urinary losses, is
consistent with a shift of calcium from the extra-
cellular to the intracellular compartment. It is there-
fore likely that the ionophore exerts its effect on
calcium distribution, not only in Vitro but also in
intact animals, without compromising the vital func-
tions, at least at the dose used by us. The lack of
significant drop in serum calcium in group 3, as op-
posed to its occurrence in group 4 is not well under-
stood. It is possible that the prolonged administra-
tion of PTH could offset the hypocalcemic effect of
ionophore in group 3, whereas with the relatively
longer administration of ionophore, a shorter admin-
istration of PTH in group 4 led to significant hypocal-
cem ia.
The cytoplasmic calcium concentration is main-
tained very low as a result of an active process which
extrudes the calcium from the cytosol at a rate which
exceeds the passive back-diffusion down a chemical
gradient. It is believed that the active energy-depen-
dent transport system operates both at the cell mem-
brane and at the mitochondrial membrane, which
accounts for the high intramitochondrial calcium
content [19,20]. Calcium ionophore (A 23187) can
increase the intracytoplasmic calcium by facilitating
the passive back diffusion to an extent that it will
exceed the active extrusion [11-13, 21,22]. The iono-
phore catalyzes transport by 1) enveloping an ion at a
membrane interphase with a consequent dehydration
of the ion, 2) diffusing across the membrane as a
cation complex, 3) releasing the ion which undergoes
concomitant rehydration at the opposite interphase,
and 4) diffusing back uncomplexed to the original
interphase to complete the catalytic process [12]. The
ionophore also enters mitochondrial membranes and
acts as a freely mobile carrier to equilibrate divalent
ion concentrations across the membranes [11]. The
ionophore, however, does not disrupt the functional
integrity of the membrane and does not interfere
directly with the energy metabolism [22]. Therefore,
ionophore plus calcium may serve as an experimental
by-pass of hormone receptors in intact cells.
The mechanism(s) by which the ionophore en-
hances tubular reabsorption of phosphorus is not
well defined by the present findings; several possi-
bilities, however, are worth comment. First, it could
act directly on the kidney to augment phosphate
transfer through a parathyroid hormone independent
system. This action could be mediated through alter-
ations in intrarenal hemodynamics, and/or through a
direct effect on tubular transport. The lack of an
antiphosphaturic response in parathyroidectomized
animals militates against this possibility and impli-
cates the presence of circulating parthyroid hormone
as an essential factor in the effect of the ionophore. It
has to be realized, however, that the low baseline
C/C1 in group 2 was an unfavorable condition for
the testing of the effect of ionophore to enhance
tubular reabsorption of phosphorus.
Second, the ionophore could act indirectly on
tubular transfer of phosphorus by suppressing secre-
tion of parathyroid hormone by the parathyroid
glands. This action could be mediated either a) by
increasing the intracytoplasmic calcium and/or b)
blocking the 1-adrenergic tone in the parathyroid
glands [23]. The latter effect has been also demon-
strated in other biologic systems [14]. The presence of
an antiphosphaturic effect of ionophore in para-
thyroidectomized rats infused with parathyroid hor-
mone suggests that the presence of parathyroid tissue
is not absolutely necessary for this effect, even though
the ionophore may alter its secretory activity. Third,
the ionophore could act on the tubular transfer of
phosphorus by blocking the phosphaturic effect of
parathyroid hormone. The observations made in para-
thyroidectomized rats receiving parathyroid hor-
mone infusion, in which the ionophore blocked the
phosphaturic response to the hormone, is consistent
with this mechanism of action. There is experimental
evidence suggesting that increased intracytoplasmic
calcium blocks the parathyroid hormone—induced ac-
tivation of renal adenylate cyclase [24,25]. In vitro
studies showed that renal cortical adenyl cyclase ac-
tivity could be blocked by calcium at concentrations
of 3 m in homogenates of tissue [25]. When similar
concentration of calcium was present in media con-
taining intact tubular cells, however, it did not have
an appreciable effect on the activity of adenyl cyclase
[26]. Theoretically, this observation suggests that the
intracellular but not the extracellular calcium concen-
tration is responsible for changes in adenyl cyclase
activity. It has been demonstrated in vitro that the
ionophore, by an increase in intracellular calcium,
may inhibit the activation of adenylate cyclase [14]. It
is possible that a similar reaction may occur in vivo
and be responsible for the observed alterations in
renal handling of phosphorus. Thus, the ionophore,
by increasing intracytoplasmic calcium, could inhibit
the parathyroid hormone-induced activation of renal
adenylate cyclase and reduce the urinary excretion of
phosphorus. The observed changes in the urinary
excretion of cAMP, both in intact and parathyroid
hormone-infused parathyroidectomized rats, lend
support to this contention. The possibility that the
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movement of magnesium down its chemical gradient
might be responsible for the observed changes cannot
be ruled out on the basis of the data available.
In the present study, renal content of cAMP was
not measured. Thus, it has not been established with
certainty that the urinary changes reflected changes in
renal formation of cAMP. These changes might rep-
resent altered cellular permeability to cAMP. Fur-
thermore ionophore might act on extrarenal organs
to suppress the release of cAMP and, thus, reduce its
urinary excretion. Almost all urinary cAMP in the rat
is derived from the nephrogenously generated cyclic
nucleotide, most of which is under the control of
parathyroid hormone [27]. Suppression of secretion
of PTH in the rat causes a marked reduction in the
nephrogeneous cAMP contribution, which accounts
for most of cAMP excreted in the urine by the rat
[27]. It is, therefore, most likely but not certain that
the observed changes in urinary cAMP in this study
represented changes in the nephrogenously generated
nucleotide.
The present findings do not rule out other cAMP
indpendent mechanisms by which increased intra-
cytoplasmic calcium could blunt the phosphaturic
action of parathyroid hormone. It is also possible
that an increase in intracellular calcium may stimu-
late the activity of guanalyl cyclase and thus increase
the generation of cyclic guanosine monophosphate(cGMP). The role of cGMP, however, in the
phosphaturic response to PTH has not been estab-
lished yet [28].
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